Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine

Maria Cristina Rapanotti1, Tonia Cenci1, Maria Giovanna Scioli1

  • 1Anatomic Pathology, Department of Integrated Care Processes, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Biomedicines
|September 28, 2024
PubMed
Summary

Circulating tumor cells (CTCs) are rare but crucial for cancer metastasis and recurrence. Advanced detection methods offer real-time insights for personalized cancer management and improved patient outcomes.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.1K